Estradiol/raloxifene (E2/RLX) is a tissue-selective estrogen complex (TSEC) which was studied for potential use in menopausal hormone therapy but was never marketed. Today, E2/RLX is not generally used due to concerns of endometrial hyperplasia.

See also List of combined sex-hormonal preparations

References